vendredi 2 septembre 2016

Onco Actu du 2 septembre 2016

2.4 Etiologie - Portables, ondes e-m

Mobile phone health alarmists bereft of credible arguments [The Conversation]

3.1 Tabac

American Cancer Society: Tobacco Has No Place in Pharmacies [ACS]

3.2 Prévention - Obésité

More than 57,000 children become overweight or obese during primary school [Cancer Research UK]

4.1 Dép., diag. & prono. - Prostate

A Math Model May Predict Time to Relapse After Prostate Cancer Surgery [AACR]

4.12 Biopsies liquides

Blood test to spot new breast cancer subtype delays progression for twice as long [The Institute of Cancer Research]

5. Traitements

Vitamin A may help control some cases of bowel cancer [Cancer Research UK]

Engineered Stem Cells Help Identify Potential New Treatment for Medulloblastoma [NCI]

5.12 Immunothérapies

Amgen obtains global development and commercial rights from Boehringer Ingelheim for investigational BiTE immuno-oncology drug for multiple myeloma [Boehringer Ingelheim]

5.12.2 Immunothérapies - CAR-T

Hurdles abound in race to bring customized cancer treatments to masses [STAT]

5.3 Traitements - FDA, EMA,...

FDA To Hold Two-Day Hearing on Off-Label Communications [FDA Law Blog]

5.4 Traitements - Economie

NICE recommends Cancer Drugs Fund treatment for prostate cancer for routine NHS use [NICE]

Radioactive prostate cancer drug given NHS go-ahead [The Guardian]

6. Lutte contre les cancers

Fix the incentives [Nature]

Voices: Waiting for Cancer [NY Times]

6.10 Politiques

The Developing World Needs A Cancer Moonshot [Forbes]

6.4 Médico-éco

Proton therapy demand wave drives expansion of Belgium's IBA [Reuters]

6.8 Communication

Cancer surgeons hesitant to tell patients the odds of a cure [Reuters]

6.9 Controverses

Stop ignoring misconduct [Nature]